Drug shortage webinar

Marie Riehl's willingness to step outside of her professional comfort zone has allowed her to be an extraordinary patient advocate.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

My family history of breast cancer emphasized the need to take precautions seriously, especially in consideration of my two children.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

When I was diagnosed and treated for a recurrence of AML, I was given an abundance of statistical information through required medical expert orations and accredited literature.

Ludmila brings warmth and compassion to the patient, treating each individual as important.